SLC1A5 and neoplasm: The analysis was performed to reflect the status of anti-tumor immunity and the results showed that although SLC1A5 mediated antigen activation (Step 1) and motivated a variety of immune cells including T cells and macrophages (Step 4), it had no role in T cell recognition and tumor killing (Step 6 and 7) (Fig. 7F).